NEW YORK, Aug. 23 – Rosetta Inpharmatics has licensed its Resolver gene expression data analyzer to functional genomics company Europroteome, Rosetta said on Thursday.

Europroteome, based in Hennigsdorf, Germany, will use the system to help it manage and analyze genomic data for its research in epithelial cancers.

Terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.